GuruFocus.com8d agobearish
Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent CliffMorgan Stanley Cuts Novo Nordisk to Underweight as Semaglutide Risks Cloud Outlook
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
76last 24h
977last 7d
110● bullish (7d)
126● bearish (7d)
212publishers
The Wall Street Journal23d agobearish
Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth ConcernsThe stock has tumbled 70% since its June 2024 peak, as the drugmaker has contended with intensifying competition from rival Eli Lilly as well as knockoff versions of its blockbuster Ozempic diabetes and Wegovy weight-loss jabs.